Valnoctamide

CAS No. 4171-13-5

Valnoctamide( —— )

Catalog No. M33528 CAS No. 4171-13-5

Valnoctamide (Valmethamide) has antiepileptic and anticonvulsant activity and can be used in the study of neurological disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
2MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Valnoctamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Valnoctamide (Valmethamide) has antiepileptic and anticonvulsant activity and can be used in the study of neurological disorders.
  • Description
    Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine-refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GABA Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4171-13-5
  • Formula Weight
    143.23
  • Molecular Formula
    C8H17NO
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (698.18 mM)
  • SMILES
    O=C(N)C(CC)C(C)CC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Spampanato J, et al. Valnoctamide enhances phasic inhibition: a potential target mechanism for the treatment of benzodiazepine-refractory status epilepticus. Epilepsia. 2014 Sep;55(9):e94-8.?
molnova catalog
related products
  • L-Threonic acid Calc...

    Threonic acid is probably derived from glycated proteins or from the degradation of ascorbic acid. It is a normal component is aqeous humour and blood. Threonic acid is a substrate of L-threonate 3-dehydrogenase in ascorbate and aldarate metabolism pathway.

  • NMS-859

    NMS-859 is an effective and covalent inhibitor of valosin-containing protein (VCP)/p97 with IC50s of 0.37 μM and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.

  • (D-Bpa13,Tyr19)-MCH ...

    (D-Bpa13,Tyr19)-MCH (human, mouse, rat)